Last reviewed · How we verify
NCT04579068
Decreasing Alcohol Use Through Student Peer Leaders
NA trial testing Screening and Brief Intervention of Problematic Alcohol Use in Alcohol Abuse. Withdrawn.
21 August 2026
Quick facts
| Lead sponsor | Charles Drew University of Medicine and Science |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | screening |
| Start date | 21 August 2021 |
| Primary completion | 21 August 2026 |
| Estimated completion | 20 October 2026 |
Drugs / interventions tested
- Screening and Brief Intervention of Problematic Alcohol Use
Conditions studied
- Alcohol Abuse — all drugs for Alcohol Abuse →
- Alcohol Drinking — all drugs for Alcohol Drinking →
- Alcohol Use Disorder — all drugs for Alcohol Use Disorder →
- Alcohol Problem — all drugs for Alcohol Problem →
Sponsor
Charles Drew University of Medicine and Science
Who can join
18 and older, any sex, with Alcohol Abuse or Alcohol Drinking. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Problematic alcohol use can lead to worse social and health related consequences for underserved minorities, requiring urgent intervention. By training underserved minority health professional students, this proposed project will develop and test the feasibility of an innovative and culturally tailored intervention for adults studying at a minority institution, with specific focus on alcohol screening, brief intervention, and referral of treatment (SBIRT). This proposal is expected to have a positive impact on alcohol reduction and prevention for minority communities
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04579068
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Alcohol Abuse
Currently open trials in the same condition.
- NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
- NCT07216872 — Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use · NA · recruiting
- NCT06415721 — Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder · NA · recruiting
- NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
- NCT06265506 — Virtual Incentive Treatment for Alcohol · NA · recruiting
Other Charles Drew University of Medicine and Science trials
Trials by the same sponsor.
- NCT06075732 — ACTIVATE in Public Housing · NA · completed
- NCT05605028 — A Mental Health Intervention for a Community Program Called the PowerObesity · NA · withdrawn
- NCT04542395 — COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents · NA · withdrawn
- NCT05805306 — Entre Herman@s: Promoting Health Among Latino MSM · NA · completed
- NCT05471141 — Preventing and Managing Cognitive Impairment · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04579068 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charles Drew University of Medicine and Science
- Last refreshed: 19 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04579068.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing